Business Wire

PANASONIC

Del
"Zoo of Light" at Donation Ceremony: Panasonic Donates 110 Solar Lanterns to Indonesian Villages

Panasonic donated 110 solar lanterns and shades to the village of Sone, in West Timor, Indonesia, which has no access to electricity. The lanterns featured shades bearing animal designs that were submitted to an international design campaign called "Cut Out the Darkness." Villagers enjoyed a special moment when all the lights were turned on at once, making a "zoo of light" appeared before everyone's eyes.

[Video] Cut Out The Darkness / Lantern'zoo in Indonesia Flash Report
https://www.youtube.com/watch?v=uDOu7XoW6vs
[Photo] Flash Report: Cut Out the Darkness Lantern'zoo Donation in Indonesia
http://panasonic.net/sustainability/en/lantern/2015/02/cotd2.html
[Project Website] Cut Out the Darkness
http://cotd.panasonic.net/

This donation was a part of Panasonic's fiscal 2014 (to end of March 2015) activities for its "100 Thousand Solar Lanterns Project," in which a total of 100,000 solar lanterns will be donated to off-grid communities around the world by 2018. That year happens to be the hundredth anniversary since Panasonic was founded.

In hopes of getting more people to know about the challenges faced by people who live without access to electricity, the "Cut Out the Darkness" project invites people to participate by personally designing shades for the lanterns. Selected designs are then turned into actual shades and donated together with solar lanterns to homes and schools in areas without electricity. For the first round, 111 designed shades and solar lanterns were donated to Sumba Island in Indonesia in March 2014.

For the second round, Panasonic called for design submissions with animal motifs. Thanks to collaboration from the Behance Japan Tokyo Community, an online portfolio for artists and designers, Panasonic received more than 300 designs from around the world.

This time, 110 pairs of solar lanterns and shades with designs chosen by popular online vote were donated to the village of Sone in East Nusa Tenggara, Indonesia. When all the lanterns were switched on at once by villagers during the donation ceremony, a "zoo of light" appeared from the darkness, before everyone's eyes. Information summarizing the project will soon be released on the project website .

This is the second year Panasonic made donations to Indonesia in its "100 Thousand Solar Lanterns Project." Panasonic donated 1,000 solar lanterns in March 2014 and a Panasonic-sponsored Japanese famous football team named GAMBA Osaka donated ten solar lanterns in January 2015 to Sumba Island and Sabu Island. In February 2015, 1,010 solar lanterns (including those donated through "Cut Out the Darkness") were delivered to the Institute of Business and Economic Democracy Foundation (IBEKA), an NGO that supports communities by introducing renewable energy, and to Kopernik, an NGO that delivers innovative technology and products to communities in the developing world with the greatest need. Thus a grand total of over 2,000 have been donated so far to Indonesia.

Currently, about 1.3 billion people live without access to electricity worldwide. Homes in these regions commonly use kerosene lamps for lighting, but the fire and smoke from these lamps pose serious fire and health risks. Panasonic solar lanterns can be used as lighting at night, thanks to the battery, which stores energy generated by sunlight during the daytime. The lanterns also reduce the inherent danger of fire from kerosene lamps, as well as health hazards from smoke, and CO2 emissions. Solar lanterns are expected to solve some of the challenges faced by areas that have no access to electricity.

The "100 Thousand Solar Lanterns Project" utilizes Panasonic's technologies and products to help solve social challenges in emerging and developing countries that have poor electrical power conditions, by making donations to non-profit/non-governmental, humanitarian, and international organizations. For Asia, Panasonic expanded its list of recipient countries this fiscal year to include Malaysia, in addition to Indonesia, Cambodia, Myanmar, India and the Philippines, which previously received lanterns.

Panasonic plans to continue working on the "100 Thousand Solar Lanterns Project" as part of its efforts to pursue "A Better Life, A Better World" and to contribute to the achievement of the United Nations Millennium Development Goals (MDGs).

Related Links:

[Press Release] Panasonic Donates 1,020 Solar Lanterns to People of East Nusa Tenggara (Feb 17, 2015):
http://panasonicapac.mynewsdesk.com/pressreleases/panasonic-donates-1-020-solar-lanterns-to-people-of-east-nusa-tenggara-1122990

Cut Out the Darkness: http://cotd.panasonic.net/
100 Thousand Solar Lanterns Project: http://panasonic.net/sustainability/en/lantern/
[Feature Story] 100 THOUSAND SOLAR LANTERNS PROJECT: http://news.panasonic.net/stories/series/solar_lantern_project/

100 Thousand Solar Lanterns Project Facebook Page: http://www.facebook.com/PanasonicSolarLantern

Contact:

COTD Project Office: info-cotd@hit-bits.com
or
Panasonic Corporation
Global Communication Group
Public Relations Office
+81-3-3574-5729
presscontact@ml.jp.panasonic.com

Link:

Multimedia Gallery

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM31.8.2025 11:15:00 CEST | Press release

− Sustained Benefit of Vutrisiran Across Mortality, Cardiovascular Events, Quality of Life and Cardiac Biomarkers Observed Through Up to 48 Months, Including 12 Months from the Ongoing Open-Label Extension, Reinforce Potential as First-Line Treatment for ATTR-CM –− Vutrisiran, which Delivers Rapid Knockdown of Transthyretin, Reduced the Risk of Composite of All-Cause Mortality or First Cardiovascular Event by 37% in the Overall Population and 42% in the Monotherapy Group During the Same Period – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. Data from the 12-month follow-up of the ongoing open-label extension (OLE) period of HELIOS-B were presented during an oral session at the European Society of Card

WETEX Opens Broad Investment Horizons for International Companies31.8.2025 08:30:00 CEST | Press release

DEWA will organise the exhibition from 30 September to 2 October 2025 Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) will organise the 27th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250830023664/en/ WETEX opens broad investment horizons for international companies (Photo: AETOSWire) WETEX embodies the UAE's pioneering position in clean and renewable energy and sustainability. It also supports Dubai's ambitious vision of a sustainable economy. The exhibition covers multiple areas including water, energy, smart cities, green mobility, artificial i

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 18:00:00 CEST | Press release

Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort of the MILOS study support the real-world effectiveness and safety of bempedoic acid in both sexes.6 Simulation using SANTORINI data reveals the potential of improved LDL-C goal attainment with tailored oral combination therapy of statins, ezetimibe and bempedoic acid, in line with the latest 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.7,8 Daiichi Sankyo has a long-standing commitment to easing treatment of cardiovascular disease (CVD) and exploring new treatment options that improve CVD outcomes and treatment adherence. Daiich

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 16:30:00 CEST | Press release

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 -- Zilebesiran Demonstrated Clinically Meaningful Reductions in Office Systolic Blood Pressure in Patients with Uncontrolled Hypertension and High Cardiovascular Risk at Month 3 Primary Endpoint, with Continuous Control Through Month 6 -- Zilebesiran Displayed Encouraging Safety When Combined with Two or More Antihypertensives -- Results Support Biannual Dosing Regimen and Inform Phase 3 Trial Design: Trial Expected to Initiate by Year-End 2025 -- Alnylam to Host Webcast Investor Event on August 30, 2025, at 1:00 pm ET (7:00 pm CEST) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from t

Andersen Consulting styrker sine kompetencer inden for virksomhedstransformation med Fabric29.8.2025 17:01:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform gennem en samarbejdsaftale med Fabric, der er et strategisk designfirma, der arbejder med organisationer for at integrere bæredygtighed, forsyningskæder og menneske-centreret innovation på tværs af kultur og drift. Fabric blev grundlagt i Japan i 2021 og arbejder sammen med virksomheder og globale brands om at skabe regenerative forretningsmodeller sammen samt bæredygtige brandstrategier og fremtidssikrede produkter. Ved hjælp af strategiske designmetoder og designfilosofi skaber virksomheden indsigtsbaseret transformation på tværs af forsyningskæder, brand og HR. Fabric er kendt for sin systemtænkning og sit engagement i social og miljømæssig bæredygtighed og fremmer desuden digitale transformationsinitiativer, der integrerer bæredygtighed, humankapital og AI. "Fabric er skabt for at hjælpe virksomheder med at blomstre gennem regenerative relationer til mennesker, samfund og forbundne, levende systemer," sagde James Hollow, der er grundlægger a

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye